Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides
/in Dendritic Cells, International Publications, Prostate Cancer /von 1997-09-01 / Prostate 1997 Sep;32(4):272-8Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen
/in Dendritic Cells, International Publications, Prostate Cancer /von 1996-12-01 / Prostate 1996 Dec;29(6):371-80Feasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostate
/in Hyperthermia, International Publications, Prostate Cancer /von 1993-05-20 / Int. J. Radiat. Oncol. Biol. Phys. 1993 May;26(2):253-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors
- Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
- Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy